Amicus Therapeutics, Inc. (FOLD)
9.805
-0.04
(-0.46%)
USD |
NASDAQ |
Dec 09, 16:00
9.805
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics EPS Diluted (Quarterly): 0.0558 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| ANI Pharmaceuticals, Inc. | 1.133 |
| Beam Therapeutics, Inc. | -1.099 |
| Catalyst Pharmaceuticals, Inc. | 0.4153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.31M |
| Revenue (Quarterly) | 169.06M |
| Total Expenses (Quarterly) | 151.76M |
| Enterprise Value | 3.218B |
| Gross Profit Margin (Quarterly) | 87.38% |
| Profit Margin (Quarterly) | 10.24% |
| Earnings Yield | -0.45% |
| Operating Earnings Yield | 1.15% |
| Normalized Earnings Yield | -0.4171 |